Exploring Amorphous Materials for Pharmaceutical Innovation
Overcoming solubility barriers and preserving protein integrity
Overcoming solubility barriers and preserving protein integrity
Amorphous materials possess distinctive physicochemical properties that unlock new formulation possibilities. By decoding molecular relaxation dynamics via dielectric spectroscopy, my research advances amorphous science to drive innovation in the following domains:
Enhancing Drug Solubility and Stability: Many promising drug candidates are hindered by poor aqueous solubility, resulting in limited bioavailability. By converting crystalline drugs into their amorphous form, we elevate their free energy state—dramatically improving solubility. Our work leverages this principle to design polymer-based formulations that stabilize amorphous drugs, optimizing both stability and dissolution performance.
Stabilizing Therapeutic Proteins: Monoclonal antibodies (mAbs) and other protein therapeutics are reshaping modern medicine, yet their solution-phase instability poses formulation challenges. Freeze-drying offers a robust pathway to solid-state stabilization, with disaccharides playing a pivotal role in preserving protein conformation and bioactivity. Through a deep understanding of molecular mobility, we identify optimal excipients to develop stable, freeze-dried protein formulations grounded in the principles of amorphous science.
Dielectric Relaxation and Ion Dynamics in Disordered Systems: Dielectric spectroscopy is a versatile tool for investigating dielectric relaxation and ion dynamics. While permittivity and ac-conductivity dispersions are traditionally used to investigate these phenomena separately, we have taken a new approach. We created a combined conductive and relaxation model—incorporating both 'pinned-dipole' and 'free-dipole' concepts—that has been applied to several disordered systems to provide a deeper physical understanding.